George M. Adjabeng

发表

Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B‐RafV600E mutation

A. Waterson, A. King, B. Heidrich, 2009 .

Suzuki cross-coupling reactions of aryl halides in phosphonium salt ionic liquid under mild conditions.

James McNulty, Alfredo Capretta, A. Robertson, 2002, Chemical communications.

Novel class of tertiary phosphine ligands based on a phospha-adamantane framework and use in the Suzuki cross-coupling reactions of aryl halides under mild conditions.

A. Robertson, J. McNulty, A. Capretta, 2003, Organic letters.

Mild conditions for Pd-catalyzed conversion of aryl bromides to primary anilines using benzophenone imine

K. Hornberger, George M. Adjabeng, Swapna Bhagwanth, 2009 .

Phospha-adamantanes as ligands for palladium-catalyzed cross-coupling reactions

George M. Adjabeng, 2003 .

A mild, one-pot synthesis of disubstituted benzimidazoles from 2-nitroanilines

Ronda G. Davis-Ward, K. Hornberger, George M. Adjabeng, 2006 .

Room-temperature Pd-catalyzed amidation of aryl bromides using tert-butyl carbamate.

A. Waterson, K. Hornberger, George M. Adjabeng, 2009, The Journal of organic chemistry.

Phosphaadamantanes as ligands for palladium catalyzed cross-coupling chemistry: library synthesis, characterization, and screening in the Suzuki coupling of alkyl halides and tosylates containing beta-hydrogens with boronic acids and alkylboranes.

J. Britten, A. Robertson, J. McNulty, 2004, The Journal of organic chemistry.

Palladium complexes of 1,3,5,7-tetramethyl-2,4,8-trioxa-6-phenyl-6-phosphaadamantane: synthesis, crystal structure and use in the Suzuki and Sonogashira reactions and the alpha-arylation of ketones.

A. Robertson, J. McNulty, A. Capretta, 2004, The Journal of organic chemistry.

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.

Alastair J. King, Alex G. Waterson, A. Waterson, 2013, ACS medicinal chemistry letters.

GSK2818713, a novel biphenylene scaffold-based Hepatitis C NS5A replication complex inhibitor with broad genotype coverage.

R. Hamatake, W. Kazmierski, R. Crosby, 2020, Journal of medicinal chemistry.

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.

J. Jackson, T. J. Lansing, R. Mook, 2009, Bioorganic & medicinal chemistry letters.

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.

April Wong, J. E. Robinson, Jim Li, 2009, Bioorganic & medicinal chemistry letters.

Rhodium Phosphinates as Catalysts for Metal-Stabilized Carbene Chemistry: Synthesis, Characterization, and Application of Rh2(O2PMe2)4

A. Capretta, David A. Gerritsma, George M. Adjabeng, 2006 .

Mild Conditions for Pd‐Catalyzed Conversion of Aryl Bromides to Primary Anilines Using Benzophenone Imine.

K. Hornberger, George M. Adjabeng, Swapna Bhagwanth, 2009 .

Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup.

A. Waterson, O. Rossanese, A. King, 2011, Bioorganic & medicinal chemistry letters.

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones.

J. E. Robinson, J. Blake, C. Oshiro, 2009, Bioorganic & medicinal chemistry letters.